Member Info for Monty888

I thought it was 4.8p not 0.48p no?

I am aware that the Bina Bawi field is the biggest best asset in the area. This is a real blow as it seems to be some sort of relationship breakdown where both parties in whose best interest this should be in just can’t connect. Almost as a lesson and a poke the KRG are being super nice to GKP up the road. Even starting to settle some of their legacy payment issues. We need to merge with GKP and leverage the relationship or something similar. My thoughts are there might be strange things a foot here and a much bigger picture. Who really knows as aside the BOD. GLA (It would be so nice if things can get back on a positive foot). GLA.

Hi Pault
Did you check out London’s Rev bars or anyone else. If there is pent up demand and enough staff then we can potentially see a re-rating of 22p to 25p depending just how busy they are after the 5th October trading update. GLA

It’s a decent strategy, reduce capital expenditure and milk the assets as the KRG are completely unethical and do respect nor play fair with the investors in their own back yard. If KRG paid their debts and were positive and fair share price would be double. Hopefully something will change, next door Genel are now at the point of litigation against the KRG as a point of last resort. Risky but shouldn’t be. Great news for now, I’m heavily invested here and hope for the best. GLA

We know next results are mid December, this is very cash generative, cash rich high margin company that really does have a bright future with Flu, Covid and various other Bio detectors. It also has the cash to diversify. I’m quite sure any news releases from now are going to be very positive, we may also have a court or out of court settlement before December as well. This would tick every box of Warren Buffet from an invest perspective. A few months patience and I think 500p to 600p is not a stretch at all, needs consistency and a little time. Very exited about short / medium term growth. Probably longer term also but need more data and results. It looks like H2 is bad as H1 is 80% of annual revenue predictions, I find this hard to understand, everything else looks really compelling. GLA

I think various forms of COVID will be a permanent feature now globally. It’s best we have the instant tests before flights at the airport and similar upon arrival and no one without 2 jabs allowed to travel (standard H&S) to protect everyone. We just need this standardized and it’s close O think with these PCR or LFT test kits like Novacyt make. I think we maybe still got another 6-8 months of standardizing this so travel can normalize and it should remove the need for 14 days isolation as people are twice proven clear on flight entry and exit. Anyway this is my hope and I don’t see why it is not workable. Emirates and Qatar and others are doing this now between agreed destinations I believe. Rajendra need some of overflow / normalization from Heathrow, Gatwick and Manchester airports that will be the priorities I think.

MJ Hudson (AIM:MJH), the international solutions provider to the asset management industry has been notified that Matthew Hudson, Chief Executive, purchased on the 19th and 20th August 40,000 ordinary shares of nil par value in the Company ('Ordinary Shares') at a blended price of 54.4p per share. Following this notification, Mr Hudson holds a direct beneficial interest in 38,946,521 Ordinary Shares (representing 22.6% of the shares in issue).

Well after a little drift lower MJH coming back. Tipped by Midas and this could be a really great investment. Looking forward to the next results to see how the acquisitions are contributing to the top and bottom lines.

As announced on 21 May 2021, the DHSC sales of £40.8 million are in dispute.

From the last update, £20m probably already been offered in either replacements or refunds but that doesn’t cover consequential losses and that’s probably the biggy

Hi Wilson, read that but that’s just the BOD that’s not the view of the plaintiff probably. I’m sure replacements have already been offered for a quick settlement but not good enough seems the to be the current status. I do think it will get resolved at lower than the provision and that delta gets transferred back into the P&L, hence then I think we will kick to around 500 pennies. (Of course it’s all logical speculation at the end of the day). The people that really know are the BOD, we are not in a closed period and they are not buying…..Mmmh

Trying to quantify why we are in this trading range to be self effacing as I’m now 25% of my portfolio in Ncyt. Last year revenue £211M, this year RNS estimates less than half. Then we have the legal action c£40M provisioned and other players chasing the market so margins looking like 70% to 50%. Also perception is growth is only Covid related and whilst in the middle of it we are shrinking per the Y/E £100m estimates. So what is fair value if you look at the negatives? My take is now £5 and if Ncyt can show revenue growth above £100m following year with sustained margins greater than 50% we are looking at a £8 to £9 share. I think we need to come in above forecast of £100m (I think we will looking at H1 and also get the settlement closed out at under £40m before anything SP upside significant happens. Ncyt would be a great acquisition for one of the big vaccine companies like Astra, Pfizer, Moderna as they have global Sales channels established so acquiring Ncyt would be immediately earnings enhancing and this is my hope. I think a take out price would be around £6. (Too low and undervalues the company but that’s why you would buy it and it does have risk). Governance will still to stand on its merits and why is the GM the CEO and biggest BOD shareholder off. The others have very small holdings and are not adding at all - Why not?

Be interested in others analysis and balanced views who understand how to analyse risk and numbers rather than noise without data folks that hog and bore with no value adding comments. (Balanced views and data help everyone).

Having lost my shirt a few years ago on a company called Quindell Portfolio and being privy to working with various CEO’s etc and knowing some City insiders. Don’t think your give it rest comment shows any class at all.

All adds up to being oversold with the bad news and some baked in the price. Looks like the Interims will come out around 22nd Dec ish. That looks likely to be the catalyst for a significant upside to me. As said patience but looks very good indeed assuming accounts etc are truthful as always. Cheers Folks - GLA.

Does anyone k ow why we were 1,176p in Jan and only 420p today?
Is purely down to the £20 - £30M provision per the litigation. If so that’s easy covered from the near £100M free cash on hand. With future growth per guidance looks like we will be back to £10 to £11 by Christmas. Am I missing anything at all folks?

RE: still over-valuedToday 12:28
It’s almost as if the market is realising that a circa £250m mcap is too high for a company with zero income, zero proven reserves and not enough cash remaining to drill another well without a substantial placing.
Billions of shares in issue, incredible dilution and it won’t stop, no way to make money here at all. It’s amazing people are invested and seem not to understand how to analyse financial fundamentals. Sadly fools and their money are soon parted.

I am invested here, but agree with you sisteract. All the good news is backed in at the current SP (market cap). If the new contracts grow the bottom line strongly we will start to move up. It’s certainly looks like a good long term bet from the customers being acquired (Let’s see after some maturity how the margins pan out).

The tree shake is reversing now as predicted at 390p in my previous post, now 400p. My guess is about 405p at close - Day traders are enjoying this one especially with the narrow spread and zero stamp duty. (Patience and buy the dips is my mantra / advice)

Lots of small sales and tree shaking allowed me to get another £20k at 390p. I’ll top again if it continues. Buffet once said, successful investing is akin to the patient taking money from the impatient. :) GLA. (Oh and don’t sell, it will blow through).

One to watch, still very much under the radar. Director Buys give an indication. Looking forward to results and forward earnings statements in the results. (This BIRD will fly). Glad to on board. GLA

Thank you both for sharing your understandings. I would like to top up but like things simple:
Eg: No abnormal international divi taxes, same trading access as always without any International trading fees or currency exchanges on BHP at least. Can see what the merger is all about down the road as it says 2022 completions. Thanks again GLA